The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts. With the next attempts expected to be years away, top researchers now say there is a…
US researchers have developed a new test to identify antibodies capable of fighting most strains of HIV, the virus that causes AIDS, in a breakthrough that could accelerate the hunt for a vaccine. A report published in the journal Science on Thursday said that scientists at the National Institute of…
US researchers said Monday that a high-profile HIV vaccine trial that was shown to work in just under a third of patients may have been hindered by feuding antibodies. The vaccine trial, known as RV144, involved more than 16,000 HIV negative volunteers in Thailand and used two investigational vaccines in…
Scientists on a quest for an antibody-based AIDS vaccine said Wednesday they found promising clues in the uncommonly “robust” natural immune response of a patient in Africa. Studying blood samples over a three-year period after the person was infected, researchers were witness to a microscopic battle between the virus and…
In the battle to prevent HIV, the United States has officially turned to its northern neighbor for a possible solution. The Food and Drug Administration (FDA) announced Tuesday that an HIV vaccine developed by Canadian scientists has been approved for human trials, according to the CBC. Researchers from the University of…
After the discovery of the HIV virus in 1984, many people both in and out of the medical community assumed that an effective vaccine would soon be developed. And yet, 30 years after its identification, that goal still seems far off. Despite the enormous amount of thought, effort and money…